The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates Academic Article uri icon

Overview

MeSH Major

  • Ductus Arteriosus, Patent
  • Infant, Premature
  • Natriuretic Peptide, Brain
  • Neonatal Screening
  • Point-of-Care Systems

abstract

  • Bedside measurement of BNP correlates with magnitude of PDA in premature newborns, particularly beyond day 2, and may be useful in guiding diagnostic and management strategies.

publication date

  • July 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jpeds.2005.03.040

PubMed ID

  • 16027692

Additional Document Info

start page

  • 38

end page

  • 42

volume

  • 147

number

  • 1